Relief Therapeutics Holding AG (RLFTF)

[changes_iv]

“Two years into a pandemic and with a death toll exceeding a reported 900,000 Americans, it is unacceptable that the FDA and NIAID are needlessly delaying a treatment for late-stage COVID-19 with a remarkable track record of success. This bureaucratic dragging of your feet appears in stark contrast to the expedited review of other treatments like remdesivir, Molnupiravir, Paxlovid and the COVID-19 vaccines. The FDA’s disparate review processes for different treatments that appears to favor large manufacturers is troubling.”

https://amgreatness.com/2022/03/09/in-letter-to-fda-and-niaid-ron-johnson-demands-to-know-why-promising-late-stage-covid-drug-was-never-approved/

There is another important element in the national vaccine program, which is the requirement to keep the vaccine production facilities up and running. These facilities are producing a biological product; they must be kept in production or the process for re-licensure is onerous, if not impossible. In the case of seasonal flu, one of the justifications for the yearly vaccine is to keep the manufacturing plants running and ready for business in case of a truly severe strain of flu or some other, unknown pathogen become a threat.  If those facilities are moth-balled, they can’t be brought back on line quickly. Bet you did not know that. One major reason for pushing annual influenza vaccines is to maintain influenza vaccine manufacturing capacity. The industry term used is “warm base manufacturing”. Of course, this results in a very nice annual “cash cow” for the vaccine industry, one which gets annually milked for a tidy guaranteed profit. The term “rent seeking behavior” applies. The same is true of the various “biodefense” vaccines and products which are maintained in the “strategic national stockpile”. In the context of Smallpox, these include ACAM2000. These products have half lives, which is to say that even though they are (hopefully) not used, they still have to be replaced every few years. Again, nice predictable profit. The corporation “Emergent Biololutions” has become particularly adept at exploiting this “market opportunity”, and has managed to monopolize many of the biodefense-related vaccines and products which the US Government purchases for the Strategic National Stockpile, including ACAM2000.

https://rwmalonemd.substack.com/p/safe-and-effective

In early 2000, Fauci shook hands with Bill Gates in the library of Gates’ $147 million Seattle mansion, cementing a partnership that would aim to control an increasingly profitable $60 billion global vaccine enterprise with unlimited growth potential. Through funding leverage and carefully cultivated personal relationships with heads of state and leading media and social media institutions, the Pharma-Fauci-Gates alliance exercises dominion over global health policy.

The Real Anthony Fauci details how Fauci, Gates, and their cohorts use their control of media outlets, scientific journals, key government and quasi-governmental agencies, global intelligence agencies, and influential scientists and physicians to flood the public with fearful propaganda about COVID-19 virulence and pathogenesis, and to muzzle debate and ruthlessly censor dissent.

https://rumble.com/vw1m5b-the-real-anthony-fauci-introduction-chapter-two.html